8-K Announcements
6Material company update
May 13, 2026·SEC
Material company update
Mar 24, 2026·SEC
Material company update
Feb 19, 2026·SEC
COMPASS Pathways plc(CMPS)Earnings, Financials & Key Ratios
CMPS•NASDAQ
Price updated Jun 19, 2026
AboutCOMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.Show more
- Revenue$0
- EBITDA-$179M-0.5%
- Net Income-$288M-85.6%
- EPS (Diluted)-3.08-33.9%
- ROE-565.28%-593.2%
CMPS Key Insights
COMPASS Pathways plc (CMPS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 96 (top 4%)
✗Weaknesses
- ✗Profits declining 36.5% over 5 years
- ✗Weak Piotroski F-Score: 2/9
- ✗Shares diluted 38.6% in last year
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CMPS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CMPS Price & Volume
COMPASS Pathways plc (CMPS) stock price & volume — 10-year historical chart
Loading chart...
CMPS Growth Metrics
COMPASS Pathways plc (CMPS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-29.86%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-58.29%
Return on Capital
10 Years-88.42%
5 Years-95.56%
3 Years-132.02%
Last Year-251.8%
CMPS Recent Earnings
COMPASS Pathways plc (CMPS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)
Q2 2026Latest
May 13, 2026Metric
Actual
Est
EPS
$0.30+33.3%
$0.45
Rev
—
—
Q2 2026
Mar 24, 2026Metric
Actual
Est
EPS
$0.59-43.9%
$0.41
Rev
—
—
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.38+5.0%
$0.40
Rev
—
—
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$0.38-2.7%
$0.37
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 13, 2026 | $0.30vs $0.45+33.3% | — |
| Q2 2026 | Mar 24, 2026 | $0.59vs $0.41-43.9% | — |
| Q4 2025 | Nov 4, 2025 | $0.38vs $0.40+5.0% | — |
| Q3 2025 | Jul 31, 2025 | $0.38vs $0.37-2.7% | — |
Based on last 12 quarters of dataView full earnings history →
CMPS Peer Comparison
COMPASS Pathways plc (CMPS) competitors in Virtual and consumer health clinics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MNMD | 2.04B | 20.69 | -10.04 | -102.48% | ||||
 ATAI | 1.49B | 4.06 | -1.40 | 12.28% | -190.19% | -366.21% | 0.01 | |
 CYBN | 303.86M | 6.09 | -13.66 | -81% | ||||
 SAVA | 63.77M | 1.32 | -2.54 | -95.77% | ||||
 ACAD | 3.7B | 21.62 | 9.44 | 11.87% | 34.3% | 35.65% | 0.04 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 AXSM | 12.89B | 250.50 | -68.07 | 65.55% | -26.59% | -260.01% | 2.73 | |
 ALTO | 388.01M | 5.02 | 31.38 | -4.9% | 3.16% | 12.53% | 0.40 |
Compare CMPS vs Peers
COMPASS Pathways plc (CMPS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CMPS Income Statement
COMPASS Pathways plc (CMPS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue Growth % | - | - | - | - | - | - | - | - | - |
Cost of Goods Sold | 0 | 63K | 112.87K | 0 | 0 | 0 | 0 | 0 | 0 |
COGS % of Revenue | - | - | - | - | - | - | - | - | - |
Gross Profit | 0▲ 0% | -63K▲ 0% | -112.87K▼ 79.2% | 0▲ 100.0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% |
Gross Margin % | - | - | - | - | - | - | - | - | - |
Gross Profit Growth % | - | - | -79.16% | 100% | - | - | - | - | - |
Operating Expenses | 10.54M | 18.45M | 51.68M | 83.22M | 110.4M | 136.92M | 178.21M | 179.04M | 172.25M |
OpEx % of Revenue | - | - | - | - | - | - | - | - | - |
Selling, General & Admin | 3.59M | 8.62M | 28.03M | 39.19M | 45.35M | 49.4M | 59.17M | 60.6M | 58.26M |
SG&A % of Revenue | - | - | - | - | - | - | - | - | - |
Research & Development | 8.92M | 12.56M | 23.37M | 44.03M | 65.05M | 87.52M | 119.04M | 118.44M | 110.07M |
R&D % of Revenue | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | -2.68M | -2.73M | 286.91K | 0 | 0 | 0 | 0 | 0 | 1000K |
Operating Income | -12.5M▲ 0% | -21.18M▼ 69.4% | -51.79M▼ 144.5% | -83.22M▼ 60.7% | -110.4M▼ 32.7% | -136.92M▼ 24.0% | -178.21M▼ 30.2% | -179.04M▼ 0.5% | -172.25M▲ 0% |
Operating Margin % | - | - | - | - | - | - | - | - | - |
Operating Income Growth % | - | -69.39% | -144.55% | -60.68% | -32.66% | -24.02% | -30.15% | -0.47% | - |
EBITDA | -12.48M | -21.12M | -51.68M | -83.05M | -110.07M | -136.68M | -177.97M | -178.82M | -36.59M |
EBITDA Margin % | - | - | - | - | - | - | - | - | - |
EBITDA Growth % | - | -69.19% | -144.74% | -60.69% | -32.54% | -24.17% | -30.21% | -0.48% | 80.65% |
D&A (Non-Cash Add-back) | 22K | 63K | 112.87K | 175K | 330K | 242K | 233K | 216K | 179K |
EBIT | -10.54M | -22.33M | -65.05M | -71.54M | -91.1M | -115.48M | -149.05M | -285.82M | -176.78M |
Net Interest Income | 0 | 0 | - | 0 | 0 | 2.42M | 3.79M | 2.67M | 2.35M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 4.62M | 8.27M | 7.18M | 7.2M |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 2.2M | 4.48M | 4.52M | 4.85M |
Other Income/Expense | -716K | 1.58M | -13.26M | 11.68M | 19.31M | 19.23M | 24.68M | -111.3M | -12.01M |
Pretax Income | -13.22M▲ 0% | -19.6M▼ 48.2% | -65.05M▼ 231.9% | -71.54M▼ 10.0% | -91.1M▼ 27.3% | -117.68M▼ 29.2% | -153.53M▼ 30.5% | -290.33M▼ 89.1% | -184.26M▲ 0% |
Pretax Margin % | - | - | - | - | - | - | - | - | - |
Income Tax | 0 | 15K | -4.25M | 199K | 408K | 780K | 1.59M | -2.47M | -5.31M |
Effective Tax Rate % | 0% | -0.08% | 6.53% | -0.28% | -0.45% | -0.66% | -1.04% | 0.85% | 2.88% |
Net Income | -13.22M▲ 0% | -19.61M▼ 48.4% | -60.8M▼ 210.0% | -71.74M▼ 18.0% | -91.5M▼ 27.5% | -118.46M▼ 29.5% | -155.12M▼ 30.9% | -287.86M▼ 85.6% | -178.95M▲ 0% |
Net Margin % | - | - | - | - | - | - | - | - | - |
Net Income Growth % | - | -48.36% | -210.03% | -17.99% | -27.55% | -29.46% | -30.94% | -85.57% | -29.86% |
Net Income (Continuing) | -13.22M | -19.61M | -60.8M | -71.74M | -91.5M | -118.46M | -155.12M | -287.86M | -178.95M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -2.35▲ 0% | -0.90▲ 61.7% | -1.68▼ 86.7% | -1.79▼ 6.5% | -2.16▼ 20.7% | -2.32▼ 7.4% | -2.30▲ 0.9% | -3.08▼ 33.9% | -1.91▲ 0% |
EPS Growth % | - | 61.7% | -86.67% | -6.55% | -20.67% | -7.41% | 0.86% | -33.91% | -58.29% |
EPS (Basic) | -2.35 | -0.90 | -1.68 | -1.79 | -2.16 | -2.32 | -2.30 | -3.08 | - |
Diluted Shares Outstanding | 5.62M | 21.72M | 35.93M | 40M | 42.44M | 51.03M | 67.48M | 93.5M | 93.64M |
Basic Shares Outstanding | 5.62M | 21.72M | 35.93M | 40M | 42.44M | 51.03M | 67.48M | 93.5M | 110.06M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
CMPS Balance Sheet
COMPASS Pathways plc (CMPS) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 26.28M | 32.17M | 202.4M | 295.3M | 191.65M | 261.3M | 201.29M | 191.49M | 510.87M |
Cash & Short-Term Investments | 22.91M | 24.97M | 190.33M | 273.24M | 143.21M | 220.2M | 165.08M | 149.61M | 466.01M |
Cash Only | 22.91M | 24.97M | 190.33M | 273.24M | 143.21M | 220.2M | 165.08M | 149.61M | 466.01M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 0 | 0 | 0 | 11.22M | 15.62M | 28.93M | 21.82M | 15.39M | 0 |
Days Sales Outstanding | - | - | - | - | - | - | - | - | - |
Inventory | 943K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
Other Current Assets | 3.37M | 6.99M | 8.92M | 2.31M | 1.22M | 2.33M | 2.58M | 26.5M | 44.86M |
Total Non-Current Assets | 108K | 218K | 1.05M | 5.6M | 5.64M | 14.69M | 12.38M | 18.86M | 20.87M |
Property, Plant & Equipment | 108K | 218K | 245K | 4.09M | 2.62M | 4.73M | 2.19M | 3.42M | 2.86M |
Fixed Asset Turnover | - | - | - | - | - | - | - | - | 0.00x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 0 | 0 | 529K | 525K | 469K | 469K | 469K | 10.95M | 10.95M |
Other Non-Current Assets | 0 | 0 | 278K | 213K | 327K | 6.16M | 5.94M | 734K | 13.91M |
Total Assets | 26.39M▲ 0% | 32.39M▲ 22.8% | 203.46M▲ 528.2% | 300.9M▲ 47.9% | 197.29M▼ 34.4% | 275.99M▲ 39.9% | 213.67M▼ 22.6% | 210.35M▼ 1.6% | 531.74M▲ 0% |
Asset Turnover | - | - | - | - | - | - | - | - | 0.00x |
Asset Growth % | - | 22.75% | 528.16% | 47.89% | -34.43% | 39.89% | -22.58% | -1.55% | 73.8% |
Total Current Liabilities | 1.85M | 23.87M | 6.89M | 15.11M | 15.6M | 19.6M | 34.02M | 247.79M | 153.8M |
Accounts Payable | 694K | 1.32M | 2.75M | 2.56M | 4.76M | 5.89M | 12.28M | 15.22M | 10.88M |
Days Payables Outstanding | - | 7.68K | 8.88K | - | - | - | - | - | - |
Short-Term Debt | 0 | 21.09M | 0 | 0 | 0 | 0 | 5.51M | 19.63M | 2.05M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 52K | 656K | 5.29M | 6.19M | 8.09M | 9.24M | 212.94M | 140.87M |
Current Ratio | 14.24x | 1.35x | 29.36x | 19.55x | 12.29x | 13.33x | 5.92x | 0.77x | 3.32x |
Quick Ratio | 13.72x | 1.35x | 29.36x | 19.55x | 12.29x | 13.33x | 5.92x | 0.77x | 3.32x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 38.91M | 0 | 0 | 1.38M | 418K | 30.64M | 24.95M | 15.4M | 51.26M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 28.76M | 24.65M | 1.29M | 779K |
Capital Lease Obligations | 0 | 0 | 0 | 1.38M | 418K | 1.88M | 303K | 0 | 5.56M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 38.91M | 0 | 0 | 0 | 0 | 0 | 0 | 14.11M | 50.48M |
Total Liabilities | 40.75M | 23.87M | 6.89M | 16.49M | 16.01M | 50.24M | 58.97M | 263.2M | 205.05M |
Total Debt | 0 | 21.09M | 0 | 3.61M | 1.93M | 33.05M | 32.19M | 20.93M | 2.83M |
Net Debt | -22.91M | -3.88M | -190.33M | -269.63M | -141.28M | -187.15M | -132.89M | -128.68M | -463.18M |
Debt / Equity | - | 2.48x | - | 0.01x | 0.01x | 0.15x | 0.21x | - | 0.01x |
Debt / EBITDA | - | - | - | - | - | - | - | - | -0.08x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | 12.66x |
Interest Coverage | - | - | - | - | - | -52.40x | -33.28x | -63.28x | -36.46x |
Total Equity | -14.37M▲ 0% | 8.52M▲ 159.3% | 196.56M▲ 2207.6% | 284.41M▲ 44.7% | 181.28M▼ 36.3% | 225.74M▲ 24.5% | 154.69M▼ 31.5% | -52.85M▼ 134.2% | 326.69M▲ 0% |
Equity Growth % | - | 159.28% | 2207.6% | 44.69% | -36.26% | 24.53% | -31.47% | -134.16% | -175.72% |
Book Value per Share | -2.56 | 0.39 | 5.47 | 7.11 | 4.27 | 4.42 | 2.29 | -0.57 | 3.49 |
Total Shareholders' Equity | -14.37M | 8.52M | 196.56M | 284.41M | 181.28M | 225.74M | 154.69M | -52.85M | 326.69M |
Common Stock | 122K | 111K | 367K | 435K | 440K | 635K | 702K | 973K | 1.39M |
Retained Earnings | -17.95M | -37.56M | -97.9M | -169.64M | -261.15M | -379.61M | -534.73M | -822.59M | -731.39M |
Treasury Stock | -3.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -435K | -98K | 14.61M | 8.84M | -16.87M | -16.93M | -16.19M | -14.79M | -14.79M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CMPS Cash Flow Statement
COMPASS Pathways plc (CMPS) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -9.8M | -17.81M | -41.38M | -67.75M | -105.45M | -97.38M | -119.19M | -157.24M | -159.52M |
Operating CF Margin % | - | - | - | - | - | - | - | - | - |
Operating CF Growth % | - | -81.75% | -132.3% | -63.71% | -55.66% | 7.66% | -22.4% | -31.93% | -66.14% |
Net Income | -13.22M | -19.61M | -60.33M | -71.74M | -91.5M | -118.46M | -155.12M | -287.86M | -178.95M |
Depreciation & Amortization | 22K | 63K | 112K | 175K | 330K | 242K | 233K | 216K | 179K |
Stock-Based Compensation | 1.42M | 3.25M | 17.98M | 8.64M | 13.12M | 17.28M | 19.52M | 13.59M | 12.55M |
Deferred Taxes | 0 | 0 | -221K | 22K | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 2.68M | 1.14M | 1.99M | 1.8M | 3.27M | 86K | 4.46M | 131.1M | 14.34M |
Working Capital Changes | -704K | -2.66M | -912K | -6.64M | -30.67M | 3.48M | 11.72M | -14.28M | -7.8M |
Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -12K | 580K | 1.3M | -163K | 2.5M | 864K | 6.59M | 2.03M | 1.81M |
Cash from Investing | -130K | -165K | -628K | -334K | -596K | -64K | 0 | 0 | 0 |
Capital Expenditures | -130K | -165K | -131K | -334K | -596K | -66K | 0 | 0 | 0 |
CapEx % of Revenue | - | - | - | - | - | - | - | - | - |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 0 | 0 |
Cash from Financing | 32.96M | 18.38M | 194.16M | 156.65M | 1.04M | 173.83M | 63.82M | 140.71M | 362.81M |
Debt Issued (Net) | 0 | 18.43M | 0 | 0 | 0 | 29.59M | 0 | 0 | 18.55M |
Equity Issued (Net) | 0 | 0 | 194.14M | 154.79M | 440K | 144.94M | 26.22M | 141.04M | 344.14M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 32.96M | -55K | 16K | 1.85M | 600K | -690K | 37.6M | -328.82K | 115.87K |
Net Change in Cash | 21.86M▲ 0% | 2.08M▼ 90.5% | 165.37M▲ 7862.1% | 82.99M▼ 49.8% | -129.97M▼ 256.6% | 77.26M▲ 159.4% | -55.17M▼ 171.4% | -15.48M▲ 71.9% | 205.9M▲ 0% |
Free Cash Flow | -9.93M▲ 0% | -17.98M▼ 81.0% | -41.51M▼ 130.9% | -68.08M▼ 64.0% | -106.05M▼ 55.8% | -97.44M▲ 8.1% | -119.19M▼ 22.3% | -157.24M▼ 31.9% | -159.52M▲ 0% |
FCF Margin % | - | - | - | - | - | - | - | - | - |
FCF Growth % | - | -81.03% | -130.9% | -64% | -55.77% | 8.11% | -22.31% | -31.93% | -10.77% |
FCF per Share | -1.77 | -0.83 | -1.16 | -1.70 | -2.50 | -1.91 | -1.77 | -1.68 | -1.70 |
FCF Conversion (FCF/Net Income) | 0.74x | 0.91x | 0.68x | 0.94x | 1.15x | 0.82x | 0.77x | 0.55x | 0.89x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 1.25M | 3.07M | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 2.44M | 1.12M | 0 | 0 |
CMPS Key Ratios
COMPASS Pathways plc (CMPS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -230.24% | -59.3% | -29.83% | -39.3% | -58.21% | -81.55% | -565.28% | -151.02% |
Return on Invested Capital (ROIC) | -342.26% | -714.38% | -593.95% | -302.28% | -261.3% | -442.54% | - | 117.15% |
Debt / Equity | 2.48x | - | 0.01x | 0.01x | 0.15x | 0.21x | - | 0.01x |
Interest Coverage | - | - | - | - | -52.40x | -33.28x | -63.28x | -36.46x |
FCF Conversion | 0.91x | 0.68x | 0.94x | 1.15x | 0.82x | 0.77x | 0.55x | 0.89x |
Related:CMPS Dividend History·CMPS Revenue History·CMPS Price History·CMPS P/E History·CMPS Financial Ratios·CMPS Institutional Holders
CMPS SEC Filings & Documents
COMPASS Pathways plc (CMPS) SEC filings — annual & quarterly reports (10-K, 10-Q)
CMPS Frequently Asked Questions
COMPASS Pathways plc (CMPS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
COMPASS Pathways plc (CMPS) grew revenue by 0.0% over the past year. Growth has been modest.
COMPASS Pathways plc (CMPS) reported a net loss of $178.9M for fiscal year 2025.
Dividend & Returns
COMPASS Pathways plc (CMPS) has a return on equity (ROE) of -565.3%. Negative ROE indicates the company is unprofitable.
COMPASS Pathways plc (CMPS) had negative free cash flow of $159.5M in fiscal year 2025, likely due to heavy capital investments.